Home
Transactions

Work Area: Transactions

BlackBerry will re-start monetisation of remaining patents if sale closes this quarter

CEO John Chen says company will use a third party to extract value from 2,000 patents it is keeping

The European Commission’s SEP licensing plans are terrible on every level

Reported DG Grow proposals designed to make FRAND dealmaking in Europe more transparent, predictable and efficient are one-sided and poorly thought-through, so will do much more harm than good

Janssen’s latest move against Amgen highlights shifting pharma patent strategies

J&J subsidiary makes innovative use of IP acquired in $6.5 billion Momenta acquisition

Latest content

Nokia strikes deal to commercialise non-core, cooling technology IP

Collaboration with Innventure is the latest attempt to realise the value of innovations outside the company's strategic focus

14 June 2022

Patent transactions in Q1 2022

Featured in Secondary Market Activity

Latest data from AST points to a steep decline from the previous year’s numbers, but there are some indications that more licensing is being done

08 June 2022

GSK’s $3.3 billion buyout shows vaccine IP boom goes beyond mRNA

Affinivax acquisition based on platform tech licensed from Boston Children’s Hospital

06 June 2022

AT&T’s billion dollar secret sauce

Scott Frank, President and CEO of the company’s IP operation, reveals how its team of patent developers takes a venture capital approach to interactions with inventors and lawyers to ensure the development of a highly diversified, revenue-generating, portfolio of rights

01 June 2022

BlackBerry's $600 million patent sale hits trouble

Company now exploring other options after proposed buyer fails to secure financing by the end of May deadline

01 June 2022

Monetising data, machine learning’s most valuable asset

Co-published – Key issues to consider when developing an exploitation strategy

26 May 2022

Toshiba continues patent dealing in wireless and LED

Recent assignments come as conglomerate solicits takeover bids that could result in ownership change for one of Japan’s biggest IP portfolios

25 May 2022

Five key IP takeaways from Pfizer’s $11.6 billion Biohaven buyout

The industry's biggest deal of 2022 focuses on a small number of patent-protected assets

20 May 2022

IPBC Global 2022 approaches sell-out territory

The world’s pre-eminent event focusing on IP value creation takes place in Chicago from 12 to 14 June with over 500 senior delegates set to attend

19 May 2022

Hyundai Motor steps up patent buying activity

Korean automaker adds portfolios from Intel and IBM as it continues to show interest in UAV and natural language processing tech

19 May 2022

Unlock unlimited access to all IAM content